放疗联合化疗治疗肺癌合并上腔静脉综合征临床研究
详细信息 查看官网全文
- 论文作者：丁富强 ; 乔红梅 ; 杨文武 ; 谭换明
- 年：2016
- 作者机构：西安医学院附属宝鸡医院肿瘤科;
- 论文关键词：化疗 ; 放疗 ; 上腔静脉综合征 ; 肺癌
- 英文论文关键词：chemotherapy ; Radiation therapy ; Superior vena cava syndrome ; Lung cancer
- 会议召开时间：2016年6月
- 会议录名称：2016《中国组织化学与细胞化学》杂志临床研究研讨会论文汇编
- 语种：中文
- 分类号：R734.2
- 学会代码：ZHXB
- 会议名称：2016《中国组织化学与细胞化学》杂志临床研究研讨会
- 会议地点：中国北京
- 主办单位：《中国组织化学与细胞化学杂志》社有限公司
- 学会名称：《中国组织化学与细胞化学杂志》社有限公司
- 页数：1
- 文件大小：171k
- 原文格式：O
- 会议级别：全国
摘要
目的:探讨肺癌合并上腔静脉综合征采取放疗联合化疗治疗的疗效。方法:选取58例于2013年5月至2014年5月期间我院接收的肺癌合并上腔静脉综合征患者,根据治疗方式不同分为对照组(放疗疗法,n=29)和实验组(放疗联合化疗,n=29),观察两组治疗4周后的临床疗效。结果:治疗4周后,实验组较对照组临床有效率显著提高(P<0.05),具有显著性差异;两组毒副反应发生率比较无明显差异(P>0.05)。结论:对肺癌合并上腔静脉综合征患者采取放疗联合化疗治疗可增强疗效,不良反应与单独放疗治疗基本一致,故可在临床上广泛应用。
Objective:to explore the lung cancer merger of superior vena cava syndrome treated with radiotherapy combined chemotherapy curative effect.Methods:58 cases selected from May 2013 to May 2014 patients with lung cancer receiving in our combined superior vena cava syndrome,according to different treatment were divided into control group(radiation therapy,n- 29) and experimental group(radiotherapy combined chemotherapy,n- 29),observe the clinical effects of the two groups after treatment of 4 weeks.Results:4 weeks after treatment,the experimental group than control group in clinical effectiveness significantly increased(P < 0.05),with significant difference:Two groups of adverse reaction rate was no significant difference(P > 0.05).Conclusion:in patients with lung cancer combined superior vena cava syndrome treated with radiotherapy combined chemotherapy can enhance curative effect,adverse reactions and radiation therapy alone,therefore,can be widely used in clinic.
Objective:to explore the lung cancer merger of superior vena cava syndrome treated with radiotherapy combined chemotherapy curative effect.Methods:58 cases selected from May 2013 to May 2014 patients with lung cancer receiving in our combined superior vena cava syndrome,according to different treatment were divided into control group(radiation therapy,n- 29) and experimental group(radiotherapy combined chemotherapy,n- 29),observe the clinical effects of the two groups after treatment of 4 weeks.Results:4 weeks after treatment,the experimental group than control group in clinical effectiveness significantly increased(P < 0.05),with significant difference:Two groups of adverse reaction rate was no significant difference(P > 0.05).Conclusion:in patients with lung cancer combined superior vena cava syndrome treated with radiotherapy combined chemotherapy can enhance curative effect,adverse reactions and radiation therapy alone,therefore,can be widely used in clinic.
引文
[1]葛方红,谢国栋,顾红芳等.综合疗法治疗肺癌合并上腔静脉综合征19例临床观察[J].浙江临床医学,2015,17(1):57—58.
[2]张伟,管峦,殷海涛等.血管内支架置入联合放疗治疗肺癌合并上腔静脉综合征的临床观察[J].临床肿瘤学杂志,2013,18(3):249—251.
[3]徐健,张秀兵,倪峰等.60例肺癌并上腔静脉综合征患者血液中D-二聚体、CEA、CYFRA21-1水平变化及意义[J].肿瘤学杂志,2016,22(3):218—221.
[4]Karim Sebaa.Mounir Bouhedda,Abdelhalim TIemc-ani et al.Location and tuning of TCPSTs and SVCs based on optimal power flow and an improved cross-entropy approach[J].International journal of electrical power and energy systems,2014,54(Jan.):536-545.
[5]李芳娟,孙希文,梁世雄等.血管内支架治疗非小细胞肺癌合并上腔静脉综合征的疗效[J].中华肿瘤杂志,2015,37(1):47—51.
[2]张伟,管峦,殷海涛等.血管内支架置入联合放疗治疗肺癌合并上腔静脉综合征的临床观察[J].临床肿瘤学杂志,2013,18(3):249—251.
[3]徐健,张秀兵,倪峰等.60例肺癌并上腔静脉综合征患者血液中D-二聚体、CEA、CYFRA21-1水平变化及意义[J].肿瘤学杂志,2016,22(3):218—221.
[4]Karim Sebaa.Mounir Bouhedda,Abdelhalim TIemc-ani et al.Location and tuning of TCPSTs and SVCs based on optimal power flow and an improved cross-entropy approach[J].International journal of electrical power and energy systems,2014,54(Jan.):536-545.
[5]李芳娟,孙希文,梁世雄等.血管内支架治疗非小细胞肺癌合并上腔静脉综合征的疗效[J].中华肿瘤杂志,2015,37(1):47—51.